100
Participants
Start Date
May 16, 2025
Primary Completion Date
December 4, 2025
Study Completion Date
March 31, 2026
HS-10542
"1. SAD：HS-10542 capsule (5 predefined dose cohorts ) will be administered orally once on Day 1.~2. Food Effect \[FE\] study：HS-10542 capsule (in one predefined dose cohort ) will be administered orally once on Day 15."
HS-10542 Placebo
SAD：HS-10542 capsule placebo (5 predefined dose cohorts ) will be administered orally once on Day 1
HS-10542
MAD：HS-10542 capsule (5 predefined dose cohorts ) will be administered orally once or twice from Day 1 to Day 10.
HS-10542 Placebo
MAD：HS-10542 capsule placebo (5 predefined dose cohorts ) will be administered orally once or twice from Day 1 to Day 10.
RECRUITING
The Affiliated Hospital of Qingdao University, Qingdao
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
INDUSTRY